AIV Logo AIV Assistant

 Logo Abbott Laboratories - ABT 135.62 USD

P/E
35.79
EPS
3.29
Yield
1.73%
P/B
5.13
ROE
14.84
Beta
0.72
Target Price
129.87 USD

135.620 USD

135.620 USD

Daily: +0.00%
Key Metrics

Earnings date: Oct. 16, 2024

P/E: 35.79

EPS: 3.29

Book Value: 22.94

Price to Book: 5.13

Debt/Equity: 37.59

% Insiders: 0.531%

Growth

Revenue Growth: 0.05%

Earnings Growth: 0.15%

Estimates

Forward P/E: 22.83

Forward EPS: 5.16

Target Mean Price: 129.87

Dividend

Dividend Yield: 1.73%

Annual dividends: 2.28 USD

Ex-Div. Date: April 15, 2025

Payout: 28.92%

5y avg Yield: 1.67%

 Logo About Abbott Laboratories - (ABT)

Country: United States

Sector: Health Care

Website: http://www.abbott.com

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Exchange Ticker
GER (Germany) ABL.DE
NYQ (United States) ABT
MIL (Italy) ABT.MI
EBS (Ireland) ABT.SW
FRA (Germany) ABL.F
STU (Germany) ABL.SG
BUE (Argentina) ABT.BA
MEX (Mexico) ABT.MX
SGO (Chile) ABT.SN
VIE (Austria) ABT.VI
SGO (Chile) ABTCL.SN
SAO (Brazil) ABTT34.SA
Dividend Yield

1.73% (5y avg: 1.67%)

Annual Dividends

2.28 USD

Next ex. div date

April 15, 2025

Payout Ratio

28.92%

Historical Dividends
Year Total Dividends
2026 1.33 USD
2025 2.42 USD
2024 2.20 USD
2023 2.04 USD
2022 1.88 USD
2021 1.80 USD
2020 1.44 USD
2019 1.28 USD
2018 1.12 USD
2017 1.06 USD
2016 1.04 USD
2015 0.96 USD
2014 0.88 USD
2013 0.56 USD
2012 0.96 USD
2011 0.90 USD
2010 0.83 USD
2009 0.75 USD
2008 0.67 USD
2007 0.61 USD
2006 0.56 USD
2005 0.52 USD
2004 1.84 USD
2003 0.44 USD
2002 0.41 USD
2001 0.37 USD
2000 0.33 USD
1999 0.30 USD
1998 0.26 USD
1997 0.30 USD
1996 0.21 USD
1995 0.18 USD
1994 0.17 USD
1993 0.15 USD
1992 0.13 USD
1991 0.11 USD
1990 0.09 USD
1989 0.08 USD
1988 0.06 USD
1987 0.07 USD
1986 0.05 USD
1985 0.04 USD
1984 0.03 USD
1983 0.03 USD

Yearly aggregated dividends

Dividends

Abbott Laboratories
May 15, 2025 Paid
Dividend
0.59 USD
Abbott Laboratories
Feb 14, 2025 Paid
Dividend
0.59 USD
Abbott Laboratories
Nov 15, 2024 Paid
Dividend
0.55 USD
Abbott Laboratories
Aug 15, 2024 Paid
Dividend
0.55 USD

Historical Split Corporate Actions

Split Date Split Ratio to 1
May 3, 2004 1.07
Jan. 2, 2013 2.08
Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion